Revision of the Sapporo criteria for the antiphospholipid syndrome - Coming to grips with evidence and Thomas Bayes?

Thrombosis and Haemostasis

Volumn 95, Issue 6, 2006, Pages 917-919

  Lackner, Karl J ^a   Peetz, Dirk ^a   Von Landenberg, Philipp ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING DISORDER; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RECURRENT ABORTION; SENSITIVITY AND SPECIFICITY; STROKE; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BAYES THEOREM; BETA 2-GLYCOPROTEIN I; DIAGNOSTIC ERRORS; FEMALE; GLYCOPROTEINS; HUMANS; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; PRACTICE GUIDELINES; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; THROMBOSIS;

EID: 33745303538     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-03-0132     Document Type: Editorial

References (15)

1. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211-4.
2. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients. Medicine 1999; 78: 167-75.
3. Ruiz-Irastorza G, Egurbide MV, Ugalde J, Aguirre C. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med 2004; 164: 77-82.
4. Mok CC, Tang SSK, To CH, et al. Incidence and risk factors of thromboembolism in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 2774-82.
5. Galli M, Luciani D, Bertolini G, et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827-32.
6. McNeil HP, Simpson RJ, Chesterman CN, et al. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotin H). Proc Natl Acad Sci USA 1990; 87: 4120-4.
7. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-11.
8. APASS Investigators. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004; 291: 576-84.
9. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
10. Faden D, Tincani A, Tanzi P, et al. Anti-β2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-β2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 73: 37-42.
11. Lee RM, Branch DW, Silver RM. Immunoglobulin A anti-β2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death. Am J Obstet Gynecol 2001; 185: 748-53.
12. Galli M, Luciani D, Bertolini G, et al. Anti-β2-glycoprotein, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003; 102: 2717-23.
13. Reber G, de Moerloose P. Anti-β2-glycoprotein antibodies - when and how should they be measured. Thromb Res 2004; 114: 527-31.
14. Detkova D, Gil-Augado A, Lavilla P, et al. Do antibodies to β2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome? Lupus 1999; 8: 430-8.
15. Obermoser G, Bitterlich W, Kunz F, et al. Clinical significance of anticardiolipin and anti-β2-glycoprotein I antibodies. Int Arch Allergy Immunol 2004; 135: 148-53.